‹ LibraryCalculate a dose →ARA-290 (Cibinetide) on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.
ARA-290 (Cibinetide)
Immune & Anti-InflammatoryResearch Use Only
Also known as: Cibinetide, Helix B surface peptide
A small peptide derived from EPO (without the blood-cell effects), studied for nerve pain and small-fiber nerve repair.
Dosing quick reference
research referenceStarting dose
2 mg once daily
Frequency
Once daily
Typical range
2–4 mg per day
Cycle
4–8 weeks
Titration (step-up)
Wk 1: 2 mg → Wk 2+: 4 mg
Half-life
Short
Route
Subcutaneous (research)
Common use
Tissue protection and neuropathic pain research
Common vial sizes
16 mg
Storage
Store lyophilized powder frozen; after reconstitution refrigerate at 2-8°C and use within a few weeks.
Reported side effects
Injection-site irritationGenerally well tolerated in reported research
Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.